Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies

被引:15
|
作者
Chaudhari, Ramesh [1 ]
Patel, Vishva [1 ]
Kumar, Ashutosh [1 ]
机构
[1] Ahmedabad Univ, Sch Arts & Sci, Biol & Life Sci, Cent Campus, Ahmadabad 380009, Gujarat, India
来源
NANOSCALE ADVANCES | 2024年 / 6卷 / 09期
关键词
TUMOR MICROENVIRONMENT; MACROMOLECULAR THERAPEUTICS; MAGNETIC NANOPARTICLES; SUBTYPES; PEPTIDE; WOMEN; PLUS; NANOMEDICINE; PERMEABILITY; CHEMOTHERAPY;
D O I
10.1039/d4na00086b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Breast cancer is a global health challenge with staggering statistics underscoring its pervasive impact. The burden of this disease is measured in terms of its prevalence and the challenges it poses to healthcare systems, necessitating a closer look at its epidemiology and impact. Current breast cancer treatments, including surgery, chemotherapy, radiation therapy, and targeted therapies, have made significant strides in improving patient outcomes. However, they are not without limitations, often leading to adverse effects and the development of drug resistance. This comprehensive review delves into the complex landscape of breast cancer, including its incidence, current treatment modalities, and the inherent limitations of existing therapeutic approaches. It also sheds light on the promising role of nanotechnology, encompassing both inorganic and organic nanoparticles equipped with the ability to selectively deliver therapeutic agents to tumor sites, in the battle against breast cancer. The review also addresses the emerging therapies, their associated challenges, and the future prospects of targeted drug delivery in breast cancer management. Discover the groundbreaking potential of nanotech-based targeted delivery in breast cancer therapy. Our review showcases how this innovative precision medicine approach can revolutionise treatment and improve patient outcomes.
引用
收藏
页码:2270 / 2286
页数:17
相关论文
共 50 条
  • [1] Cutting-edge technologies in colon-targeted drug delivery systems
    Patel, Mayur M.
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (10) : 1247 - 1258
  • [2] Cutting-Edge Therapies for Lung Cancer
    La'ah, Anita Silas
    Chiou, Shih-Hwa
    CELLS, 2024, 13 (05)
  • [3] From conventional to cutting-edge: Exosomes revolutionizing nano-drug delivery systems
    Fu, Huiyang
    Chen, Yinfeng
    Fu, Qingyao
    Lv, Qingqing
    Zhang, Jing
    Yang, Yang
    Tan, Peng
    Wang, Xiaozhe
    Yang, Ying
    Wu, Zhenlong
    CHEMICAL ENGINEERING JOURNAL, 2024, 500
  • [4] Microfluidics as a cutting-edge technique for drug delivery applications
    Fontana, Flavia
    Ferreira, Monica P. A.
    Correia, Alexandra
    Hirvonen, Jouni
    Santos, Helder A.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 34 : 76 - 87
  • [5] Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations
    Liu, Yan
    Lu, Kuan
    Zhang, Ruru
    Hu, Dongliang
    Yang, Zhe
    Zeng, Jianfeng
    Cai, Wu
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (12) : 3804 - 3826
  • [6] Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies
    Hong, David I.
    Bankova, Lora
    Cahill, Katherine N.
    Kyin, Timothy
    Castells, Mariana C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (01) : 43 - 52
  • [7] Cutting-Edge Achievements of Inner Ear Drug Delivery Systems
    Zhang, Hui
    Xu, Dongyu
    Wang, Huan
    Chai, Renjie
    Zhao, Yuanjin
    ADVANCED NANOBIOMED RESEARCH, 2024, 4 (06):
  • [8] Breast cancer: beyond the cutting edge
    Higa, Gerald M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2479 - 2498
  • [9] Navigating the evolution of ophthalmic drug delivery and ocular regenerative medicine from conventional to cutting-edge treatments
    Nezhad, Nadia Mostafavi
    Rahimi, Maryam
    Gheybi, Fatemeh
    Kesharwani, Prashant
    Oroojalian, Fatemeh
    Sahebkar, Amirhossein
    APPLIED MATERIALS TODAY, 2025, 42
  • [10] HEPATOBILIARY PANCREATIC CANCER: CUTTING-EDGE DRUG THERAPY
    Ioka, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 67 - 68